Evidence map›Paper›PMID 35975361›Full record

ArticleDiabetes & vascular disease research

Hyperinsulinemia alters insulin receptor presentation and internalization in brain microvascular endothelial cells.

Luke S Watson, Brynna Wilken-Resman, Alexus Williams, Stephanie DiLucia, Guadalupe Sanchez, Taylor L McLeod, Catrina Sims-Robinson

Open access · diamondAbstract read
In one paragraph

Article in Diabetes & vascular disease research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Luke S WatsonDepartment of Neurology, 2345Medical University of South Carolina, Charleston, SC, USA.
Brynna Wilken-ResmanMolecular and Cellular Biology and Pathobiology Program, 2345Medical University of South Carolina, Charleston, SC, USA.
Alexus WilliamsMolecular and Cellular Biology and Pathobiology Program, 2345Medical University of South Carolina, Charleston, SC, USA.
Stephanie DiLuciaDepartment of Neurology, 2345Medical University of South Carolina, Charleston, SC, USA.
Guadalupe SanchezMolecular and Cellular Biology and Pathobiology Program, 2345Medical University of South Carolina, Charleston, SC, USA.
Taylor L McLeodMolecular and Cellular Biology and Pathobiology Program, 2345Medical University of South Carolina, Charleston, SC, USA.
Catrina Sims-RobinsonMolecular and Cellular Biology and Pathobiology Program, 2345Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0003-4776-5839
Medical University of South Carolina · US

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Treating Depression and Enhancing Locomotor Recovery Post-strokeP20GM109040 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KAUTZ, STEVEN A. · 2014 to 2024
$23.5M
TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
MUSC Minority Student Development ProgramR25GM072643 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ERGUL, ADVIYE, RINKER, JENNIFER ANNE · 2005 to 2023
$5.8M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR001451 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2015 to 2024
$4.6M
MUSC Post-Baccalaureate Research Education ProgramR25GM113278 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DELEON-PENNELL, KRISTINE Y, PENROD-MARTIN, RACHEL · 2015 to 2024
$2.7M
Molecular Mechanisms Underlying Obesity-related Memory DeficitsR01NS099595 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROBINSON, CATRINA SIMS · 2018 to 2022
$1.8M
The Role of Diet-induced Obesity in Cognitive ImpairmentK01NS079461 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBINSON, CATRINA SIMS · 2013 to 2015
$586k
NCATS NIH HHS TL1 TR001451NCATS NIH HHS UL1 TR001450NHLBI NIH HHS T32 HL007260NIGMS NIH HHS P20 GM109040NIGMS NIH HHS R25 GM072643NIGMS NIH HHS R25 GM113278NINDS NIH HHS K01 NS079461NINDS NIH HHS R01 NS099595
6 · The paper itself

Abstract

Insulin receptors are internalized by endothelial cells to facilitate their physiological processes; however, the impact of hyperinsulinemia in brain endothelial cells is not known. Thus, the aim of this study was to elucidate the impact hyperinsulinemia plays on insulin receptor internalization through changes in phosphorylation, as well as the potential impact of protein tyrosine phosphatase 1B (PTP1B). Hippocampal microvessels were isolated from high-fat diet fed mice and assessed for insulin signaling activation, a process known to be involved with receptor internalization. Surface insulin receptors in brain microvascular endothelial cells were labelled to assess the role hyperinsulinemia plays on receptor internalization in response to stimulation, with and without the PTP1B antagonist, Claramine. Our results indicated that insulin receptor levels increased in tandem with decreased receptor signaling in the high-fat diet mouse microvessels. Insulin receptors of cells subjected to hyperinsulinemic treatment demonstrate splice variation towards decreased IR-A mRNA expression and demonstrate a higher membrane-localized proportion. This corresponded with decreased autophosphorylation at sites critical for receptor internalization and signaling. Claramine restored signaling and receptor internalization in cells treated with hyperinsulinemia. In conclusion, hyperinsulinemia impacts brain microvascular endothelial cell insulin receptor signaling and internalization, likely via alternative splicing and increased negative feedback from PTP1B.

Indexed as

HyperinsulinismReceptor, InsulinAnimalsBrainEndothelial CellsInsulinMicePhosphorylationInsulinReceptor, InsulinBlood-brain barrierhigh-fat dietneurodegenerationobesityprotein tyrosine phosphatase-1b

Identifiers

PMID35975361
PMCPMC9393688
OpenAlexW4292264153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.